MSV
ALXN

MN Services Vermogensbeheer’s Alexion Pharmaceuticals ALXN Stock Holding History

MN Services Vermogensbeheer’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-38,355
Closed -$5.02M – 634
2019
Q2 		$5.02M Hold
38,355
– – 0.06% 341
2019
Q1 		$5.18M Buy
38,355
+500
+1% +$62.2K 0.06% 332
2018
Q4 		$3.22M Buy
37,855
+2,900
+8% +$343K 0.05% 371
2018
Q3 		$4.86M Hold
34,955
– – 0.11% 197
2018
Q2 		$4.34M Hold
34,955
– – 0.11% 204
2018
Q1 		$3.9M Hold
34,955
– – 0.1% 221
2017
Q4 		$3.48M Sell
34,955
-1,900
-5% -$231K 0.11% 203
2017
Q3 		$5.17M Buy
36,855
+400
+1% +$54.3K 0.14% 176
2017
Q2 		$4.43M Buy
36,455
+30,475
+510% +$3.55M 0.12% 191
2017
Q1 		$678K Buy
5,980
+245
+4% +$31.6K 0.13% 173
2016
Q4 		$665K Hold
5,735
– – 0.14% 172
2016
Q3 		$703K Buy
5,735
+44
+0.8% +$5.66K 0.14% 164
2016
Q2 		$598K Buy
5,691
+43
+0.8% +$6.1K 0.14% 167
2016
Q1 		$690K Buy
+5,648
New +$829K 0.16% 145

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MN Services Vermogensbeheer's ALXN Position: Q3 2019 in Review

MN Services Vermogensbeheer sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 38,355 shares — an estimated $5.02M sold.

MN Services Vermogensbeheer first reported a position in ALXN in Q1 2016 and held it in 14 quarters. The position peaked at $5.18M in Q1 2019. 648 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • MN Services Vermogensbeheer reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 38,355 Alexion Pharmaceuticals shares in Q3 2019, an estimated $5.02M.
  • MN Services Vermogensbeheer first reported a position in Alexion Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • MN Services Vermogensbeheer's Alexion Pharmaceuticals position peaked at $5.18M in Q1 2019.
  • 648 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on MN Services Vermogensbeheer's 13F filing for Q3 2019, filed 12 Nov 2019.